Table 2

CRLF2 genomic rearrangements and mutations in cases tested for CRLF2 lesions

FeatureALL cases tested (n = 304)
NCI HR (n = 141)
NCI SR (n = 163)
P (log-rank)
No. of positive casesNo. of evaluable casesNot determined%No. of positive casesNo. of evaluable casesNot determined%No. of positive casesNo. of evaluable casesNot determined%
High CRLF2 expression 181 304 59.5 91 141 64.5 90 163 55.2 .103 
CRLF2 genomic rearrangements and mutations 
    IGH@-CRLF2 31 301 10.3 22 140 15.7 161 5.6 .004 
    P2RY8-CRLF2 65 304 21.4 24 141 17.0 41 163 25.2 .093 
    Either lesion* 93 304 30.6 44 141 31.2 49 163 30.1 .901 
    CRLF2 (F232C) 142 162 2.1 53 88 0.0 89 74 3.4 .293 
    Gain of locus 140 284 20 49.3 55 124 17 4.4 85 160 53.1 .153 
FeatureALL cases tested (n = 304)
NCI HR (n = 141)
NCI SR (n = 163)
P (log-rank)
No. of positive casesNo. of evaluable casesNot determined%No. of positive casesNo. of evaluable casesNot determined%No. of positive casesNo. of evaluable casesNot determined%
High CRLF2 expression 181 304 59.5 91 141 64.5 90 163 55.2 .103 
CRLF2 genomic rearrangements and mutations 
    IGH@-CRLF2 31 301 10.3 22 140 15.7 161 5.6 .004 
    P2RY8-CRLF2 65 304 21.4 24 141 17.0 41 163 25.2 .093 
    Either lesion* 93 304 30.6 44 141 31.2 49 163 30.1 .901 
    CRLF2 (F232C) 142 162 2.1 53 88 0.0 89 74 3.4 .293 
    Gain of locus 140 284 20 49.3 55 124 17 4.4 85 160 53.1 .153 
*

Either IGH@-CRLF2 or P2RY8-CRLF2.

Gain of CRLF2 locus determined by cytogenetics (+X or +Y) or FISH (extra copies of RP11-309M23).

Close Modal

or Create an Account

Close Modal
Close Modal